A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT07223723 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07223723
- Sponsor
- Biogen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-11
- Primary completion
- 2027-05-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.